Biochemical and clinical studies on epileptic patients during two phase I trials with the novel anticonvulsant taltrimide.

E M Airaksinen; K Koivisto; T Keränen; A Pitkänen; P J Riekkinen; S S Oja; K M Marnela; J V Partanen; O Tokola; G Gothóni

doi:10.1016/0920-1211(87)90008-8

Biochemical and clinical studies on epileptic patients during two phase I trials with the novel anticonvulsant taltrimide.

Identifier:nobleid.org/w1/20260515/C9ACDFEC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C9ACDFEC.svg?ark=w1%2F20260515%2FC9ACDFEC)](https://nobleid.org/work/w1/20260515/C9ACDFEC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Biochemical and clinical studies on epileptic patients during two phase I trials with the novel anticonvulsant taltrimide.

Identifier:nobleid.org/w1/20260515/C9ACDFEC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C9ACDFEC.svg?ark=w1%2F20260515%2FC9ACDFEC)](https://nobleid.org/work/w1/20260515/C9ACDFEC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work